Prophylaxis Clinical Trials in Paris
5 recruitingParis, France
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled81 locationsNCT07044297
Recruiting
Monitoring of Anti-TFPI in Hemophilia
HemophiliaRebalancing AgentsProphylaxis
Hospices Civils de Lyon11 enrolled2 locationsNCT07101926
Recruiting
Phase 3
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+3 more
University Hospital, Angers1,424 enrolled35 locationsNCT06195540
Recruiting
Not Applicable
Pharmacokinetic Characterization of a Single 200 mg Dose of Doxycycline in Post-exposure Prophylaxis (PEP) of Sexually Transmitted Infections in Different Biological Compartments
Sexually Transmitted DiseasesPost Exposure ProphylaxisDoxycycline
Assistance Publique - Hôpitaux de Paris25 enrolled2 locationsNCT06007534
Recruiting
Phase 3
Intermittent Cefoxitin Administration Versus Loading Bolus Followed by Continuous Infusion for the Prevention of Surgical Site Infection in Colorectal Surgery
Colorectal SurgeryAntibiotic Prophylaxis
Poitiers University Hospital2,000 enrolled19 locationsNCT05755789